Nath Bio-Genes (India) Balance Sheet Health
Financial Health criteria checks 5/6
Nath Bio-Genes (India) has a total shareholder equity of ₹6.1B and total debt of ₹1.1B, which brings its debt-to-equity ratio to 18.1%. Its total assets and total liabilities are ₹8.8B and ₹2.7B respectively. Nath Bio-Genes (India)'s EBIT is ₹466.0M making its interest coverage ratio 5.1. It has cash and short-term investments of ₹774.1M.
Key information
18.1%
Debt to equity ratio
₹1.10b
Debt
Interest coverage ratio | 5.1x |
Cash | ₹774.10m |
Equity | ₹6.10b |
Total liabilities | ₹2.70b |
Total assets | ₹8.80b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 537291's short term assets (₹5.7B) exceed its short term liabilities (₹2.6B).
Long Term Liabilities: 537291's short term assets (₹5.7B) exceed its long term liabilities (₹78.7M).
Debt to Equity History and Analysis
Debt Level: 537291's net debt to equity ratio (5.4%) is considered satisfactory.
Reducing Debt: 537291's debt to equity ratio has increased from 11.5% to 18.1% over the past 5 years.
Debt Coverage: 537291's debt is well covered by operating cash flow (63.7%).
Interest Coverage: 537291's interest payments on its debt are well covered by EBIT (5.1x coverage).